MENU
+Compare
CVAC
Stock ticker: NASDAQ
AS OF
May 12, 04:59 PM (EDT)
Price
$3.64
Change
+$0.17 (+4.90%)
Capitalization
781.29M

CVAC CureVac NV Forecast, Technical & Fundamental Analysis

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people... Show more

CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CVAC with price predictions
May 09, 2025

CVAC in upward trend: price rose above 50-day moving average on April 21, 2025

CVAC moved above its 50-day moving average on April 21, 2025 date and that indicates a change from a downward trend to an upward trend. In of 33 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 09, 2025. You may want to consider a long position or call options on CVAC as a result. In of 69 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CVAC just turned positive on April 09, 2025. Looking at past instances where CVAC's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for CVAC crossed bullishly above the 50-day moving average on April 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CVAC advanced for three days, in of 237 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 76 cases where CVAC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CVAC moved out of overbought territory on May 01, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 38 cases where CVAC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for CVAC moved below the 200-day moving average on April 09, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVAC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CVAC broke above its upper Bollinger Band on April 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.992) is normal, around the industry mean (14.689). P/E Ratio (4.263) is within average values for comparable stocks, (63.724). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.989). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (1.292) is also within normal values, averaging (253.495).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CVAC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVAC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CVAC is expected to report earnings to rise 7.47% to -16 cents per share on May 21

CureVac NV CVAC Stock Earnings Reports
Q1'25
Est.
$-0.16
Q4'24
Beat
by $0.09
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.04
Q1'24
Est.
$-0.31
The last earnings report on April 10 showed earnings per share of -15 cents, beating the estimate of -24 cents. With 299.82K shares outstanding, the current market capitalization sits at 781.29M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company developing tumour immunotherapy

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Friedrich-Miescher-Strasse 15
Phone
+49 707198830
Employees
1049
Web
https://www.curevac.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF
BTC.X104106.360000-589.968750
-0.56%
Bitcoin cryptocurrency

CVAC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with BNTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then BNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
-3.34%
BNTX - CVAC
46%
Loosely correlated
-2.12%
MRNA - CVAC
45%
Loosely correlated
-0.53%
ARCT - CVAC
42%
Loosely correlated
-3.51%
VXRT - CVAC
38%
Loosely correlated
+3.10%
NERV - CVAC
37%
Loosely correlated
N/A
More